Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 801–900 of 1,001
Cholinesterase and its molecular forms in pathological states
Rakonczay, Z. (1988) · Progress in Neurobiology · doi:10.1016/0301-0082(88)90017-2 · Cited by 37
Mundy, W. R., Barone, S., & Tilson, H. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90629-p · Cited by 35
(2018) · Europe PMC (PubMed Central) · Cited by 34
Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C. M., & Givalois, L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108398 · Cited by 36
Rett Syndrome: A Pervasive Developmental Disorder
Acker, R. M. V., Walberg, J. L., & Acker, E. Y. V. (2005) · Wiley eBooks · doi:10.1002/9780470939345.ch5 · Cited by 40
Sivakumar, S., Kumar, R. R., Ali, M. A., & Choon, T. S. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.050 · Cited by 34
Verapamil and Alzheimer’s Disease: Past, Present, and Future
Popović, N., Morales-Delgado, N., Mena, D. V., Alonso, A., Martínez, M. P., Bleda, M. C., & Popović, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00562 · Cited by 36
Zhou, L., Zhang, J., Tan, L., Huang, H., Zhou, Y., Liu, Z., Lu, Y., Zhu, L., Yao, C., & Liu, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667412 · Cited by 36
Goryacheva, A. V., Круглов, С. В., Pshennikova, M. G., Smirin, B. V., Malyshev, I. Y., Barskov, I. V., Викторов, И. В., Downey, H. F., & Manukhina, E. B. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.08.005 · Cited by 36
Alterations of the cerebral capillary bed in the senile dementia of Alzheimer
Scheibel, A. B. (1987) · Neurological Sciences · doi:10.1007/bf02334602 · Cited by 34
Risacher, S. L., Wang, Y., Wishart, H. A., Rabin, L. A., Flashman, L. A., McDonald, B. C., West, J. D., Santulli, R. B., & Saykin, A. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00105 · Cited by 36
Toide, K., Shinoda, M., & Miyazaki, A. (1998) · Reviews in the Neurosciences · doi:10.1515/revneuro.1998.9.1.17 · Cited by 41
Shimohama, S., & Kawamata, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_8 · Cited by 39
Olfaction in Aging and Medical Disorders
Schiffman, S. S. (1992) · Springer eBooks · doi:10.1007/978-1-4612-2836-3_18 · Cited by 34
Perl, D. P., & Pendlebury, W. W. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30974-5 · Cited by 36
GIACOBINI, E., Somani, S., McIlhany, M., Downen, M., & Hallak, M. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90059-1 · Cited by 34
Trophic Factors In Neurologic Disease
Stewart, S. S., & Appel, S. H. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.001205 · Cited by 35
Neuropathology of the Aging Brain and Dementia of the Alzheimer Type
Wísniewski, H. M., & Merz, G. (1985) · Springer eBooks · doi:10.1007/978-1-4612-5058-6_20 · Cited by 34
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
Przybyłowska, M., Dzierzbicka, K., Kowalski, S., Chmielewska, K., & Inkielewicz‐Stępniak, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x19666201218103434 · Cited by 34
Varshney, V., & Garabadu, D. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00336-y · Cited by 33
Neuropathological changes in the nucleus basalis in schizophrenia
Williams, M. R., Marsh, R., Macdonald, C., Jain, J., Pearce, R. K. B., Hirsch, S. R., Ansorge, O., Gentleman, S., & Maier, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0387-7 · Cited by 36
History of Neural Stem Cell Research and Its Clinical Application
Takagi, Y. (2016) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2015-0340 · Cited by 37
Griffith, C. M., Xie, M.-X., Qiu, W., Sharp, A. A., Ma, C., Pan, A., Yan, X., & Patrylo, P. R. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.034 · Cited by 34
Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase
Marcelo, F., Silva, F., Goulart, M., Justino, J., Sînaÿ, P., Blériot, Y., & Rauter, A. P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.057 · Cited by 33
Riekkinen, P. J., Sirviö, J., Jäkälä, P., Lammintausta, R. A. S., & Riekkinen, P. R. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90104-y · Cited by 34
Dementia With Cerebral Lewy Bodies: A Mesocortical Dopaminergic Defect?
Eggertson, D. E., & Sima, A. A. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520050094034 · Cited by 33
Hui, J., Feng, G., Zheng, C., Jin, H. M., & Jia, N. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.030 · Cited by 36
Werner, C. T., Williams, C. J., Fermelia, M. R., Lin, D., & Li, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01174 · Cited by 34
Alzheimer's disease‐like neuropathology in three species of oceanic dolphin
Vacher, M. C., Durrant, C. S., Rose, J. L., Hall, A. J., Spires‐Jones, T. L., Gunn‐Moore, F. J., & Dagleish, M. P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15900 · Cited by 32
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
Wattmo, C., Londos, E., & Minthon, L. (2014) · BMC Neurology · doi:10.1186/s12883-014-0173-4 · Cited by 30
A metabolic perspective of late onset Alzheimer’s disease
Ettcheto, M., Cano, A. C., Busquets, O., Manzine, P. R., Sánchez‐López, E., Castro-Torres, R. D., Beas‐Zárate, C., Verdaguer, E., García, M. L., Olloquequi, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104255 · Cited by 34
Muscarinic agonists in Alzheimer's disease
Growdon, J. H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00039-8 · Cited by 33
Cholinergic Function in Lumbar Aluminum Myelopathy
Kosik, K. S., Bradley, W. G., Good, P. F., Rasool, C. G., & Selkoe, D. J. (1983) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198307000-00001 · Cited by 32
Is Alzheimer's disease an immunological disorder? Observations and speculations
Fudenberg, H., Whitten, H. D., Arnaud, P., & Khansari, N. (1984) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(84)90114-4 · Cited by 34
Kalopanaxsaponins A and B Isolated from Kalopanax pictus Ameliorate Memory Deficits in Mice
Joh, E., Lee, I., & Kim, D. (2011) · Phytotherapy Research · doi:10.1002/ptr.3596 · Cited by 31
Maezono, S. E. B., Kanuka, M., Tatsuzawa, C., Morita, M., Kawano, T., Kashiwagi, M., Nondhalee, P., Sakaguchi, M., Saito, T., Saido, T. C., et al. (2020) · eNeuro · doi:10.1523/eneuro.0093-20.2020 · Cited by 32
Chen, X., Zuo, X., Becker, A., Head, E., & Mobley, W. C. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12835 · Cited by 31
Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors
Schwarz, Š., Csük, R., & Rauter, A. P. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00142g · Cited by 31
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Leko, M. B., Hof, P. R., & Šimić, G. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.016 · Cited by 32
Butt, A. E., & Bowman, T. D. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4013 · Cited by 31
Fractal analysis of cerebral blood flow distribution in Alzheimer's disease.
Nagao, M., Murase, K., Kikuchi, T., Ikeda, M., Nebu, A., Fukuhara, R., Sugawara, Y., Miki, H., & Ikezoe, J. (2001) · PubMed · Cited by 32
Fujimoto, K.-I., Yoshida, M., Ikeguchi, K., & Niijima, K. (1989) · Neuroscience Research · doi:10.1016/0168-0102(89)90024-2 · Cited by 31
Ransmayr, G. N., Cervera, P., Hirsch, É. C., Berger, W., Fischer, W., & Agid, Y. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90034-y · Cited by 31
Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
Fujiyoshi, K., Suga, H., Okamoto, K., Nakamura, S., & Kameyama, M. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.7.929 · Cited by 35
Walsh, R., Martin, E. V., & Darvesh, S. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.001 · Cited by 33
Herdick, M. L., Dyrba, M., Fritz, H.-C., Altenstein, S., Ballarini, T., Brosseron, F., Büerger, K., Cetindag, A. C., Dechent, P., Dobisch, L., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102495 · Cited by 32
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Ansari, M. A., Tripathi, T., Venkidasamy, B., Monziani, A., Rajakumar, G., Alomary, M. N., Alyahya, S. A., Onimus, O., D’souza, N., Barkat, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03730-z · Cited by 33
Härtig, W., Saul, A., Kacza, J., Grosche, J., Goldhammer, S., Michalski, D., & Wirths, O. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12050 · Cited by 34
Araujo, J. A., Nóbrega, J. N., Raymond, R., & Milgram, N. W. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.005 · Cited by 33
Effects of cytidine-diphosphocholine on acetylcholine-mediated behaviors in the rat
Drago, F., Mauceri, F., Nardo, L. G., Valerio, C., Genazzani, A. A., & Grassi, M. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90113-p · Cited by 30
Sedman, A. J., Bockbrader, H. N., & Schwarz, R. D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00023-y · Cited by 30
Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques
Nakamura, S., Arima, K., Haga, S., Aizawa, T., Motoi, Y., Otsuka, M., Ueki, A., & Ikeda, K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01042-7 · Cited by 30
Mattio, T. G., McIlhany, M., Giacobini, E., & Hallak, M. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90166-8 · Cited by 30
Acetylcholinesterase-rich pyramidal neurons in alzheimer's disease
Heckers, S., Geula, C., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90072-6 · Cited by 32
Gasbarri, A., Sulli, A., Pacitti, C., & McGaugh, J. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00672-1 · Cited by 31
Cutler, N. R., Jhee, S. S., Cyrus, P. A., Bieber, F., TanPiengco, P., Sramek, J. J., & Gulanski, B. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00082-4 · Cited by 30
Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration
Butterfield, D. A., & Boyd-Kimball, D. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)61007-5 · Cited by 31
Jacobowitz, D. M., & Heydorn, W. E. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.12.1996 · Cited by 30
Disterhoft, J. F., & Oh, M. M. (2003) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2003.08.004 · Cited by 33
Effects of Chinese herbal medicine fuzhisan on aged rats
Li, X. L., Wang, D. S., Zhao, B. Q., Li, Q., Qu, H. Y., Zhang, T., Zhou, J. P., & Sun, M. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.018 · Cited by 29
“Scientists discovered that the cholinergic system degenerates in AD, and the degree of this degeneration correlates with the degree of dementia (Perry et al., 1978; Whitehouse et al., 1981).”
BackgroundHu, Y., Lai, J., Wan, B., Liu, X., Zhang, Y., Zhang, J., Sun, D., Ruan, G., Liu, E., Liu, G., et al. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.02.012 · Cited by 31
Koulousakis, P., Andrade, P., Visser-Vandewalle, V. E. R. M., & Sesia, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180133 · Cited by 29
el‐Rady, N. M. A., Ahmed, A., Abdel‐Rady, M. M., & Ismail, O. I. (2020) · Physiological Reports · doi:10.14814/phy2.14651 · Cited by 31
Gonzalez, S., McHugh, T. L. M., Yang, T., Syriani, W., Massa, S. M., Longo, F. M., & Simmons, D. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105563 · Cited by 30
Takata, K., Kimura, H., Yanagisawa, D., Harada, K., Nishimura, K., Kitamura, Y., Shimohama, S., & Tooyama, I. (2022) · Molecules · doi:10.3390/molecules27092780 · Cited by 31
Lane, R. M., & He, Y. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.01.050 · Cited by 30
Yan, H., Pang, P., Chen, W., Zhu, H., Afewerky, H. K., Li, H., Wu, Z., Ke, X., Wu, J., Zhang, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0621-4 · Cited by 30
van Dyck, C. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.157 · Cited by 30
Boissière‐Michot, F., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00210-3 · Cited by 32
Galantamine increases excitability of CA1 hippocampal pyramidal neurons
Oh, M. M., Wu, W., Power, J., & Disterhoft, J. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.063 · Cited by 29
Alterations of some membranetransportproteins in Alzheimer's disease: role of amyloid β-peptide
Sultana, R., & Butterfield, D. A. (2007) · Molecular BioSystems · doi:10.1039/b715278g · Cited by 33
Nakagawasai, O. (2005) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.125.549 · Cited by 29
Pepeu, G., Casamenti, F., Pedata, F., Cosi, C., & Pepeu, I. M. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90024-2 · Cited by 29
Treatment of Alzheimer’s disease
Tsai, P., & Cummings, J. L. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.025 · Cited by 30
Neurophysiological alterations in caudate neurons in aged cats
Levine, M. S., Lloyd, R. L., Hull, C. D., Fisher, R. S., & Buchwald, N. A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91407-7 · Cited by 29
Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results
Boller, F., & Forette, F. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90109-1 · Cited by 30
Muscarinic agonist-mediated induction of long-term potentiation in rat cerebral cortex
Lin, Y., & Phillis, J. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90955-u · Cited by 29
Nanri, M., Kasahara, N., Yamamoto, J., Miyake, H., & Watanabe, H. (1997) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)31388-5 · Cited by 29
Substantia innominata: MR findings in Parkinson?s disease
Oikawa, H., Sasaki, M., Ehara, S., & Abe, T. (2004) · Neuroradiology · doi:10.1007/s00234-004-1257-4 · Cited by 28
Long-acting injectable donepezil microspheres: Formulation development and evaluation
Choi, G.-W., Lee, S., Kang, D. W., Kim, J. H., Kim, J. H., & Cho, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.022 · Cited by 30
Neuromelanin in the Human Brain: A Review and Atlas of Pigmented Cells in the Substantia Nigra
Usunoff, K. G., Itzev, D. E., Ovtscharoff, W. A., & Marani, E. (2002) · Archives of Physiology and Biochemistry · doi:10.1076/apab.110.4.257.11827 · Cited by 32
Gypenoside TN-2 ameliorates scopolamine-induced learning deficit in mice
Hong, S.-W., Yang, J.-H., Joh, E., Kim, H. J., & Kim, D. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.02.002 · Cited by 28
Kim, H. J., Lee, J. E., Shin, S. J., Sohn, Y. H., & Lee, P. H. (2011) · Journal of Movement Disorders · doi:10.14802/jmd.11014 · Cited by 28
Kuzmickienė, J., & Kaubrys, G. (2015) · Medical Science Monitor · doi:10.12659/msm.895381 · Cited by 29
Is Alzheimer's disease related to a deficit or malfunction of rapid eye movement (REM) sleep?
Christos, G. A. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90121-6 · Cited by 28
Jiang, H., Zhang, J., Zhu, H., Li, H., & Zhang, X. (2007) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2007.00247.x · Cited by 34
Homocysteine Thiolactone and Human Cholinesterases
Darvesh, S., Walsh, R., & Martin, E. V. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9114-0 · Cited by 30
Strategies for the protection of dopaminergic neurons against neurotoxicity
Gerlach, M., Double, K. L., Youdim, M. B. H., & Riederer, P. (2000) · Neurotoxicity Research · doi:10.1007/bf03033788 · Cited by 29
Butt, A. E., & Hodge, G. K. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.699 · Cited by 31
Jacobs, R. W., Farivar, N., & Butcher, L. L. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90094-1 · Cited by 28
Swaab, D. F., Dubelaar, E. J. G., Scherder, E., Someren, E. J. W. V., & Verwer, R. W. H. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307004-00006 · Cited by 28
Doucette, R., & Ball, M. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)90944-9 · Cited by 28
Neurotrophic factors and Alzheimer's disease
Wainer, B. H. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90122-x · Cited by 28
Mechanisms of Neuron Loss in Alzheimer’s Disease
Mukhin, V. N., Pavlov, K. I., & Klimenko, V. M. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0427-x · Cited by 27
Lenders, M.-B., Peers, M.-C., Tramu, G., Delacourte, A., Defossez, A., Petit, H., & Mazzuca, M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90812-3 · Cited by 27
A multiple hits hypothesis for memory dysfunction in Parkinson disease
Citro, S., Lazzaro, G. D., Cimmino, A. T., Giuffrè, G. M., Marra, C., & Calabresi, P. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00905-z · Cited by 28
Vafadarnejad, F., Karimpour‐Razkenari, E., Sameem, B., Saeedi, M., Firuzi, O., Edraki, N., Mahdavi, M. R., & Akbarzadeh, T. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103192 · Cited by 29
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation
Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.13 · Cited by 31
Scarpa, M., Molloy, C., Jenkins, L., Strellis, B., Budgett, R. F., Hesse, S., Dwomoh, L., Marsango, S., Tejeda, G. S., Rossi, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107389118 · Cited by 28
Zhang, X., Lin, L., Li, H., Xia, W., Liu, Q., Zhou, X., Lin, D., & Fu, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.158 · Cited by 27
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.